ArticleOncoTargets and therapy2019

EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression.

Dongwei Dou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.